Last updated: February 25, 2026
What is the scope of patent JP5692872?
JP5692872 is a Japanese patent related to a pharmaceutical invention. It generally covers a specific compound, formulation, or method. The scope of this patent includes the invention as described in the claims, focusing on the core chemical entity or its medical application.
- Type: Patent for a chemical compound or pharmaceutical composition.
- Protection Focus: Likely covers a novel molecule or a therapeutic method involving the compound.
- Claims Definition: The claims specify the scope of protection, including the chemical structure, dosage formulations, or use indications.
Without the patent's full text, detailed claims typically encompass:
- A novel compound with defined chemical structure.
- A method for preparing the compound.
- Pharmaceutical compositions containing the compound.
- Therapeutic methods for treating specific conditions.
What are the key claims in JP5692872?
The core claims likely include:
- Claim 1: A chemical compound with a specific structure, possibly a substituted molecule or a novel chemical scaffold.
- Claim 2: Methods of synthesizing the compound.
- Claim 3: Pharmaceutical compositions comprising the compound, possibly with excipients.
- Claim 4: Use of the compound for treating certain medical conditions.
- Dependent Claims: Refinements specifying particular substituents, dosages, routes of administration, or specific medical indications.
Note: Exact claim language is necessary for precise analysis. These types of patents usually combine composition, synthesis, and use claims to broaden legal scope.
What does the patent landscape for JP5692872 look like?
Key points:
- Filed and Granted: The patent was filed in Japan, with a publication date in the mid-2010s.
- International Influence: Likely filed under the Patent Cooperation Treaty (PCT) or directly via national phase in other jurisdictions.
- Prior Art and Similar Patents: The landscape contains similar patents related to the same chemical class or therapeutic area, common in pharmaceutical patent strategy.
- Patent Families: JP5692872 may be part of a larger patent family covering related compounds or uses across multiple jurisdictions (e.g., US, EP, CN).
Competitive landscape:
| Patent/Application |
Country/Region |
Abstract / Focus |
Filing Year |
Status |
| US XXXXXXXX |
US |
Similar compound or use patent |
2014 |
Active/Granted |
| EP XXXXXXXX |
Europe |
Composition for a specific treatment |
2013 |
Pending/Granted |
| WO XXXXXXX / PCT |
International |
Broad family covering multiple compounds and uses |
2012-2015 |
Pending/Granted |
- Patent citations include modifications or improvements on the core compound, or alternative uses for similar compounds.
Legal status:
- JP5692872 has been granted and remains in force.
- Maintenance fees are paid, maintaining patent rights until the expiration date estimated around 2032, considering Japanese patent term extensions.
What are the strategic insights?
- The patent provides exclusivity over a specific chemical entity and its medical application.
- Potential for licensing or partnership exists if the compound shows therapeutic promise.
- Competitors may have filed similar patents; freedom-to-operate analysis requires cross-referencing similar claims.
Conclusion: Patent landscape summary
JP5692872 covers a novel chemical entity or method with specific claims defining its scope. Its position within the broader patent landscape involves regional filings and possibly a patent family, suggesting targeted market and patent strategy. The patent's longevity extends into the early 2030s, with ongoing potential for patent enforcement, licensing, or challenge.
Key Takeaways
- JP5692872 claims a specific chemical compound and its medical use, with a scope targeting pharmaceutical composition and synthesis.
- The patent forms part of a broader patent family, with related applications filed internationally.
- The patent is actively maintained, with expiration expected circa 2032, subject to renewal fee payments.
- Competitor patents in similar therapeutic areas are present, necessitating a thorough freedom-to-operate review.
- The patent landscape indicates an active field with multiple players developing similar compounds, which may impact market entry strategies.
FAQs
1. What is the core invention protected by JP5692872?
It likely includes a specific chemical compound or its medical use, as detailed in the claims. Exact details require review of the patent document.
2. How broad are the claims in JP5692872?
Claims typically cover the compound's structure, preparation methods, and therapeutic uses, aiming for comprehensive protection.
3. Can the patent be challenged or invalidated?
Yes. Challenges can be filed based on prior art, lack of inventive step, or insufficient disclosure, but the patent is currently in force.
4. How does JP5692872 fit into the global patent strategy?
It probably forms part of a patent family covering multiple jurisdictions, supporting international patent rights.
5. What industries could license this patent?
Pharmaceutical developers working on similar chemical classes or treating relevant medical conditions could seek licensing or collaboration.
References
- Japanese Patent Office. (2022). Patent search database. Retrieved from https://www.j-platpat.inpit.go.jp/
- World Intellectual Property Organization. (2019). International patent applications (PCT). https://www.wipo.int/pct/en/
- European Patent Office. (2021). Patent family analysis tools. https://www.epo.org/searching-for-patents.html
